← Back to headlines
Zhengye Biotechnology Regains Nasdaq Compliance Amidst Share Decline
Zhengye Biotechnology has regained compliance with Nasdaq's minimum bid price requirement, though its shares experienced a decline.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Canada Announces Retaliatory Tariffs on US Goods Amid Trade Dispute
19m ago
Canada just announced new tariffs on US goods. Here’s how the growing trade war could hurt Americans - CNN
31m ago
Dick's Sporting Goods Stock Plunges on Weak Outlook and Q2 Miss
34m ago
US Tariff Threat Disrupts Copper Market, Pushing Prices Near Record Highs
42m ago